Weeks 1-2: You begin at the lowest introductory dose of 0.2 milligrams per week Weeks 3-4: Your dose increases to 0.4 milligrams per week
Because GLP-1s affect metabolic signaling, insulin sensitivity, and inflammatory pathways, their potential influence on this broader inflammatory environment has been examined
History of pancreatitis represents a relative contraindication to GLP-1 receptor agonist use
The regular weight-loss dose of 2.27mg/mL (3mL pre-filled) also dropped from 1,893.67 yuan per pen to the current price of 987.48 yuan per pen, with both experiencing a reduction of over 50%
Rapid weight loss from these medications can increase gallstone formation risk and potentially trigger complications in those with existing stones
A 2023 case series in Headache: The Journal of Head and Face Pain (Robbins et al.) reviewed 847 patients starting semaglutide and found: 14% reported headaches during the first 16 weeks Of those, 23% noted clear positional worsening (worse lying down or worse standing, depending on individual CSF dynamics) 89% of positional headaches resolved by week 20 without intervention beyond hydration 2.1% required temporary dose reduction 0.4% discontinued due to intolerable headache The positional component is underreported because patients don't always connect the pattern